Nautilus to Participate in the Morgan Stanley Global Healthcare Conference
September 03 2021 - 9:00AM
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single-molecule protein analysis platform for
quantifying the human proteome, today announced the company
will be participating virtually in the upcoming Morgan Stanley
Global Healthcare Conference.
Nautilus’ management is scheduled to present on Wednesday,
September 15th at 1:15 p.m. Eastern Time/10:15 a.m. Pacific Time.
Interested parties may access a live and archived webcast of the
presentation on the company’s website at:
https://www.nautilus.bio/investors/
About Nautilus Biotechnology, Inc.
Nautilus is a biotechnology company who is developing a
proteomics platform that aims to deliver superior sensitivity more
quickly, more completely, and less expensively than is currently
possible. Nautilus Biotechnology aims to enable a dramatic
acceleration of basic science research, significantly improve the
success rate of therapeutic development, and enhance opportunities
for personalized and predictive medicine. Nautilus’ corporate
headquarters is in Seattle, Washington and scientific research and
development is being conducted from its San Carlos, California
office and labs.
Contacts
Investors:InvestorRelations@nautilus.bio
Media:Chris BlessingtonVice President, Corporate Marketing and
Communicationschrisb@nautilus.bio
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Sep 2023 to Sep 2024